Analysis of the aetiology of epilepsy in 3,216 adult patients attending a tertiary referral center enabled by an electronic patient record.


Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 23 06 2020
revised: 04 08 2020
accepted: 06 08 2020
pubmed: 5 9 2020
medline: 29 7 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

The aim of this study was to review the causes of the epilepsies in our institution, an adult tertiary referral center for neurology and neurosurgery in Dublin, Ireland. Data was obtained from a bespoke epilepsy electronic patient record (EPR). Predetermined search parameters of well-established broad categories of epilepsy aetiology were used to identify patients with a diagnosis of epilepsy attending Beaumont Hospital, Dublin. There were 3216 patients that met the inclusion criteria for this study. We included living patients with epilepsy attending our institution. We then excluded patients with a diagnosis of pure non-epileptic attack disorder and patients found to have idiopathic generalised epilepsy (IGE) (n = 382) from our final cohort. We excluded IGE due to the complex polygenic basis underlying this patient group. An aetiology was identified in 54.3 % (n = 1747) of the total number of patients studied. Of the symptomatic epilepsies, 41.08 % (n = 1321) were acquired and 13.3 % (n = 426) were predominantly of genetic or developmental aetiology. The most common causes of the acquired epilepsies were hippocampal sclerosis (n = 380; 28.75 %), cerebral tumor (n = 279; 21.06 %), traumatic brain injury (n = 248; 18.77 %), stroke and cerebrovascular disease (n = 151; 11.43 %) and perinatal causes (n = 138; 10.45 %). The leading causes in the genetic / developmental category included cavernous haemangiomas (n = 62, 22.22 %), arteriovenous malformations (n = 59; 21.15 %) and cortical dysplasia (n = 55; 19.71 %). The aetiology of a patient's epilepsy was undetermined in 45.68 % (n = 1469) of individuals. This study emphasizes the clinical utility of the ILAE's 2017 revised classification of the epilepsies and highlights the evolving dynamic nature of attributing causality in epilepsy. This is the largest single centre analysis of the aetiology of the epilepsies described in the literature. It is also the first large scale study examining aetiology utilising a bespoke electronic patient record in epilepsy.

Identifiants

pubmed: 32883563
pii: S1059-1311(20)30241-7
doi: 10.1016/j.seizure.2020.08.005
pmc: PMC7442552
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

332-337

Informations de copyright

Copyright © 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Références

Cell. 1998 Jan 9;92(1):63-72
pubmed: 9489700
Seizure. 2012 Jan;21(1):40-4
pubmed: 22000953
Epilepsy Curr. 2014 May;14(3):121-4
pubmed: 24940151
Epilepsia. 2001 Jun;42(6):796-803
pubmed: 11422340
Nature. 1993 Aug 19;364(6439):717-21
pubmed: 8355785
Neurology. 2017 Jan 17;88(3):296-303
pubmed: 27986877
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Epilepsia. 2014 Jan;55(1):76-85
pubmed: 24116877
Epilepsia. 2010 May;51(5):845-52
pubmed: 20002142
Epilepsia. 2011 Jun;52(6):1052-7
pubmed: 21449936
Nat Rev Neurosci. 2013 May;14(5):337-49
pubmed: 23595016
Seizure. 2013 Oct;22(8):604-10
pubmed: 23537634
PLoS Med. 2009 Oct;6(10):e1000162
pubmed: 19823570
Epilepsia. 2013 Apr;54(4):751-6
pubmed: 23346906
Epilepsia. 2003 Jan;44(1):1-4; discussion 4-13
pubmed: 12581219
Epilepsia. 1992 May-Jun;33(3):450-8
pubmed: 1592018

Auteurs

S Delaney (S)

Epilepsy Programme, Beaumont Hospital, Dublin, Ireland.

M Fitzsimons (M)

SFI FutureNeuro Research Centre, Dublin, Ireland.

M White (M)

Epilepsy Programme, Beaumont Hospital, Dublin, Ireland; SFI FutureNeuro Research Centre, Dublin, Ireland.

K Power (K)

SFI FutureNeuro Research Centre, Dublin, Ireland.

S O' Donoghue (S)

Digital Practice, Ergo Group, Dublin, Ireland.

R Kilbride (R)

Epilepsy Programme, Beaumont Hospital, Dublin, Ireland.

P Widdess-Walsh (P)

Epilepsy Programme, Beaumont Hospital, Dublin, Ireland; SFI FutureNeuro Research Centre, Dublin, Ireland.

H El Naggar (H)

Epilepsy Programme, Beaumont Hospital, Dublin, Ireland; SFI FutureNeuro Research Centre, Dublin, Ireland.

N Delanty (N)

Epilepsy Programme, Beaumont Hospital, Dublin, Ireland; SFI FutureNeuro Research Centre, Dublin, Ireland; School of Pharmacy and Biomedical Sciences Royal College of Surgeons, Dublin, Ireland. Electronic address: normandelanty@beaumont.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH